louisiana glp-1 digestive blockage class action Ozempic Lawsuit [July 2026 Update] louisiana semaglutide digestive blockage law

[DOI] [Google Scholar] [11].Grimaldi L, Bovi E, Formisano R, Sancesario G

[DOI] [PMC free article] [PubMed] [Google Scholar] 41.Thingholm L.B., Rhlemann M.C., Koch M., Fuqua B., Laucke G., Boehm R., Bang C., Franzosa E.A., Hbenthal M., Rahnavard G., et al

doi: 10.1016/S2213-8587(22)00349-7

The CVOT of oral semaglutide in people with type 2 diabetes and established CVD, chronic kidney disease (CKD) or both demonstrated a significant reduction in MACE compared with placebo (McGuire et al, 2025)

So in terms of holding the drug, patients would need to stop it about a month before surgery, which isnt necessarily always possible

This test identifies key genetic variants affecting GLP-1 receptor sensitivity and peptide metabolism, helping your care team personalize your treatment protocol and predict your individual response profile